We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EDV:ASXEndeavour Group Ltd Analysis

Data as of 2026-03-14 - not real-time

A$3.73

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Endeavour Group trades at AUD 3.73, sitting below its 20‑day (3.88), 50‑day (3.81) and 200‑day (3.83) simple moving averages, while the 14‑day RSI of 42 signals a lack of buying momentum. The MACD histogram is negative and the signal line is bearish, reinforcing a short‑term downside bias, and the stock is hovering just above the calculated support of 3.72 with resistance near 4.12.
Fundamentally, the company delivers modest revenue growth of 0.9% and thin profit margins (3.1% net), but carries a heavy debt load (A$5.35 bn) resulting in a debt‑to‑equity of 134% and a payout ratio of 90%, calling the sustainability of its 4.58% dividend into question. Valuation metrics appear stretched: a forward P/E of 15.96 and a price‑to‑book of 1.68 contrast sharply with a discounted‑cash‑flow fair value of only 1.80, implying the market price is more than double intrinsic estimates, while the Fear & Greed index sits in “Greed” territory. Low beta (0.15) and a consumer‑defensive profile temper volatility, yet the 30‑day volatility of 26% and rising volume suggest heightened trading activity. The sector’s defensive nature typically implies low to medium risk, but the high leverage and dividend payout raise financial concerns. With an upside potential of roughly 5% and limited downside cushioning, the stock warrants a cautious stance.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD signal
  • Proximity to technical support level

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable consumer‑defensive sector
  • Attractive dividend yield but high payout ratio
  • Elevated debt-to-equity ratio

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • DCF fair value far below market price
  • High leverage and limited earnings growth
  • Unsustainable dividend policy

Key Metrics & Analysis

Financial Health

Revenue Growth0.90%
Profit Margin3.09%
P/E Ratio17.8
ROE9.44%
ROA4.47%
Debt/Equity134.09
P/B Ratio1.7
Op. Cash FlowA$1.1B
Free Cash FlowA$583.0M

Technical Analysis

TrendNeutral
RSI42.0
SupportA$3.72
ResistanceA$4.12
MA 20A$3.88
MA 50A$3.81
MA 200A$3.83
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueA$1.80
Target PriceA$3.91
Upside/Downside4.81%
GradeOvervalued
TypeValue
Dividend Yield4.58%

Risk Assessment

Beta0.15
Volatility26.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.